First dose of misoprostol administration at home or in hospital for medical abortion between 12-22 gestational weeks in Sweden (PRIMA): a multicentre, open-label, randomised controlled trial.
瑞典醫療流產中12-22週妊娠期間在家或醫院首次給予misoprostol的管理(PRIMA):一項多中心、開放標籤、隨機對照試驗。
Lancet 2024-08-31
Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT Randomized Clinical Trial.
妊娠高血壓後經醫師優化自我管理後的長期血壓控制:POP-HT隨機臨床試驗。
JAMA 2024-04-05
Perinatal morbidity among women with a previous caesarean delivery (PRISMA trial): a cluster-randomised trial.
先兆產婦在先前剖腹產的困擾(PRISMA試驗):一項集群隨機試驗。
Lancet 2024-01-08
Term planned delivery based on fetal growth assessment with or without the cerebroplacental ratio in low-risk pregnancies (RATIO37): an international, multicentre, open-label, randomised controlled trial.
低風險懷孕的胎兒生長評估及是否考慮腦胎盤比值進行計劃性分娩(RATIO37):一項國際、多中心、開放標籤、隨機對照試驗。
Lancet 2024-02-21
Provision of Medications for Self-Managed Abortion Before and After the Dobbs v Jackson Women's Health Organization Decision.
Dobbs v Jackson Women's Health Organization 案前後自我墮胎藥物供應。
JAMA 2024-03-28
Effect of Early vs Late Inguinal Hernia Repair on Serious Adverse Event Rates in Preterm Infants: A Randomized Clinical Trial.
早期與晚期鼠蹊疝修補對早產兒嚴重不良事件率的影響:隨機臨床試驗。
JAMA 2024-03-29
PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice.
PIONEER REAL Sweden:一項在瑞典臨床實踐中,針對成人2型糖尿病患者使用口服Semaglutide的多中心、前瞻性、真實世界觀察研究。
Diabetes Ther 2024-07-25